Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

[WebSurvCa: web-based estimation of death and survival probabilities in a cohort].

Clèries R, Ameijide A, Buxó M, Vilardell M, Martínez JM, Alarcón F, Cordero D, Díez-Villanueva A, Yasui Y, Marcos-Gragera R, Vilardell ML, Carulla M, Galceran J, Izquierdo Á, Moreno V, Borràs JM.

Gac Sanit. 2018 Jan 19. pii: S0213-9111(17)30306-0. doi: 10.1016/j.gaceta.2017.10.015. [Epub ahead of print] Spanish.

2.

Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial.

Muñoz G, de Gracia J, Buxó M, Alvarez A, Vendrell M.

Eur Respir J. 2018 Jan 11;51(1). pii: 1701926. doi: 10.1183/13993003.01926-2017. Print 2018 Jan.

PMID:
29326318
3.

Fatty acid synthase expression and its association with clinico-histopathological features in triple-negative breast cancer.

Giró-Perafita A, Sarrats A, Pérez-Bueno F, Oliveras G, Buxó M, Brunet J, Viñas G, Miquel TP.

Oncotarget. 2017 Aug 10;8(43):74391-74405. doi: 10.18632/oncotarget.20152. eCollection 2017 Sep 26.

4.

Oncological results of the educational Rectal Cancer Project in Spain 10 years after its implementation.

Codina Cazador A, Biondo S, Espin Basany E, Enriquez-Navascues JM, Garcia-Granero E, Roig Vila JV, Buxó M; en representación de los centros participantes en el Proyecto del Cáncer de Recto de la Asociación Española de Cirujanos.

Cir Esp. 2017 Dec;95(10):577-587. doi: 10.1016/j.ciresp.2017.08.007. Epub 2017 Oct 14. English, Spanish.

PMID:
29037748
5.

Predicting the cancer burden in Catalonia between 2015 and 2025: the challenge of cancer management in the elderly.

Clèries R, Ameijide A, Marcos-Gragera R, Pareja L, Carulla M, Vilardell ML, Esteban L, Buxó M, Espinàs JA, Puigdefàbregas A, Ribes J, Izquierdo A, Galceran J, Borrás JM.

Clin Transl Oncol. 2017 Oct 12. doi: 10.1007/s12094-017-1764-5. [Epub ahead of print]

PMID:
29027110
6.

miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands.

Quintana E, Ortega FJ, Robles-Cedeño R, Villar ML, Buxó M, Mercader JM, Alvarez-Cermeño JC, Pueyo N, Perkal H, Fernández-Real JM, Ramió-Torrentà L.

Mult Scler. 2017 Nov;23(13):1716-1726. doi: 10.1177/1352458516684213. Epub 2017 Jan 9.

PMID:
28067602
7.

Estimating long-term crude probability of death among young breast cancer patients: a Bayesian approach.

Clèries R, Buxó M, Yasui Y, Marcos-Gragera R, Martínez JM, Ameijide A, Galceran J, Borràs JM, Izquierdo À.

Tumori. 2016 Dec 1;102(6):555-561. doi: 10.5301/tj.5000545. Epub 2016 Sep 20.

PMID:
27647229
8.

Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.

Corominas-Faja B, Vellon L, Cuyàs E, Buxó M, Martin-Castillo B, Serra D, García J, Lupu R, Menendez JA.

Histol Histopathol. 2017 Jul;32(7):687-698. doi: 10.14670/HH-11-830. Epub 2016 Oct 7.

9.

Validation of a Spanish version of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis.

Muñoz G, Buxó M, de Gracia J, Olveira C, Martinez-Garcia MA, Giron R, Polverino E, Alvarez A, Birring SS, Vendrell M.

Chron Respir Dis. 2016 May;13(2):128-36. doi: 10.1177/1479972316632005. Epub 2016 Feb 22.

10.

Contribution of changes in demography and in the risk factors to the predicted pattern of cancer mortality among Spanish women by 2022.

Clèries R, Buxó M, Martínez JM, Espinàs JA, Dyba T, Borràs JM.

Cancer Epidemiol. 2016 Feb;40:113-8. doi: 10.1016/j.canep.2015.12.002. Epub 2015 Dec 18.

11.

Cytokeratin 5/6 fingerprinting in HER2-positive tumors identifies a poor prognosis and trastuzumab-resistant basal-HER2 subtype of breast cancer.

Martin-Castillo B, Lopez-Bonet E, Buxó M, Dorca J, Tuca-Rodríguez F, Ruano MA, Colomer R, Menendez JA.

Oncotarget. 2015 Mar 30;6(9):7104-22.

12.

An improved axillary staging system using the OSNA assay does not modify the therapeutic management of breast cancer patients.

Ruano MA, Lopez-Bonet E, Buxó M, Tuca-Rodríguez F, Vila-Camps E, Alvarez E, Martin-Castillo B, Menendez JA.

Sci Rep. 2014 Jul 18;4:5743. doi: 10.1038/srep05743.

13.

[Bioethical reflections on ill-considered care due to an early diagnosis of Alzheimer disease].

Buxó MJ, Casado M.

Gac Sanit. 2014 Sep-Oct;28(5):426-8. doi: 10.1016/j.gaceta.2014.03.012. Epub 2014 May 19. Spanish.

14.

Cancer incidence and mortality projections up to 2020 in Catalonia by means of Bayesian models.

Ribes J, Esteban L, Clèries R, Galceran J, Marcos-Gragera R, Gispert R, Ameijide A, Vilardell ML, Borras J, Puigdefabregas A, Buxó M, Freitas A, Izquierdo A, Borras JM.

Clin Transl Oncol. 2014 Aug;16(8):714-24. doi: 10.1007/s12094-013-1140-z. Epub 2013 Dec 12.

PMID:
24338506
15.

Fatty acid synthase expression is strongly related to menopause in early-stage breast cancer patients.

Porta R, Blancafort A, Casòliva G, Casas M, Dorca J, Buxo M, Viñas G, Oliveras G, Puig T.

Menopause. 2014 Feb;21(2):188-91. doi: 10.1097/GME.0b013e31829d17dc.

PMID:
23982110
16.

Time trends of cancer incidence and mortality in Catalonia during 1993-2007.

Clèries R, Esteban L, Borràs J, Marcos-Gragera R, Freitas A, Carulla M, Buxó M, Puigdefàbregas A, Izquierdo A, Gispert R, Galceran J, Ribes J.

Clin Transl Oncol. 2014 Jan;16(1):18-28. doi: 10.1007/s12094-013-1060-y. Epub 2013 Jun 6.

PMID:
23740137
17.

Bayesian approach to predicting cancer incidence for an area without cancer registration by using cancer incidence data from nearby areas.

Clèries R, Ribes J, Buxo M, Ameijide A, Marcos-Gragera R, Galceran J, Miguel Martínez J, Yasui Y.

Stat Med. 2012 May 10;31(10):978-87. doi: 10.1002/sim.4463. Epub 2012 Jan 11.

PMID:
22237653
18.

Neuroendocrine tumors: a population-based study of incidence and survival in Girona Province, 1994-2004.

Alsina M, Marcos-Gragera R, Capdevila J, Buxó M, Ortiz RM, Barretina P, Vilardell L, Brunet J, Beltran M, Izquierdo Á.

Cancer Epidemiol. 2011 Dec;35(6):e49-54. doi: 10.1016/j.canep.2011.05.011. Epub 2011 Aug 16.

PMID:
21840785
19.

Methods for the study of employment relations and health inequalities in a global context.

Benach J, Castedo A, Solar O, Martínez JM, Vergara M, Amable M, Buxó M, Demiral Y, Muntaner C.

Int J Health Serv. 2010;40(2):209-13.

PMID:
20440965
20.

[Predictions of cancer incidence and mortality in Catalonia to 2015 by means of Bayesian models].

Ribes J, Clèries R, Buxó M, Ameijide A, Valls J, Gispert R.

Med Clin (Barc). 2008 Oct;131 Suppl 1:32-41. Spanish.

PMID:
19080813
21.

What challenges offers nanotechnology to bioethics?

Susanne C, Casado M, Buxo MJ.

Rev Derecho Genoma Hum. 2005 Jan-Jun;(22):27-45.

PMID:
16385788

Supplemental Content

Support Center